Concepedia

Author

Stacey Allen

The University of Queensland

Also Known As

Stacey Allen, Stacey M. Allen

73

Publications

1.9K

Citations

16

H-Index

39

Concepts

All Affiliations

The University of QueenslandQIMR Berghofer Medical Research InstituteThe University of MelbourneJuntendo UniversityRoyal Brisbane and Women's Hospital
SA

About

Stacey Allen is an author at The University of Queensland specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

281

2

Health Sciences

2

2

107

3

Natural Sciences

1

1

70

4

Allergy

1

1

96

5

Biochemistry

1

1

70

Stacey Allen

×

16

Publications

1.9K

Citations

15

H-Index

YearCitations

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease

Jing Liu, Stephen J. Blake, Michelle C.R. Yong,

Cancer Discovery

2016

833

Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy

Stephen J. Blake, Kimberley Stannard, Jing Liu,

Cancer Discovery

2016

228

MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1

Juming Yan, Stacey Allen, Elizabeth S. McDonald,

Cancer Discovery

2019

145

Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome

Jing Liu, Jake S. O’Donnell, Juming Yan,

OncoImmunology

2019

104

Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer

Jing Liu, Stephen J. Blake, Heidi Harjunpää,

Cancer Research

2016

96

RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer

Elizabeth Ahern, Heidi Harjunpää, Jake S. O’Donnell,

OncoImmunology

2018

92

Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice

Elizabeth Ahern, Heidi Harjunpää, Deborah S. Barkauskas,

Clinical Cancer Research

2017

86

Batf3<sup>+</sup> DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy

Jing Liu, Elisa A. Rozeman, Jake S. O’Donnell,

OncoImmunology

2018

73

Dual targeting of aminoacyl-tRNA synthetases to the apicoplast and cytosol in Plasmodium falciparum

Katherine E. Jackson, James S. Pham, Michelle Kwek,

International Journal for Parasitology

2011

70

Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis

Heidi Harjunpää, Stephen J. Blake, Elizabeth Ahern,

OncoImmunology

2018

46

Page 1